Product Description

Buy Nolvadex in Canadian steroids shop. It’s convenient to pay with card.

Our bodybuilding store in Canada provides perfect quality Tamoxifen Citrate for sale online. Maxtreme Pharma’s Maxi-Fen-10 is top quality Tamoxifen Citrate 10mg 50 pills (Nolvadex) from famous Anti Estrogens producer.

Our online pharmacy delivers Anti Estrogens across Canada, so we can ship your order to you fast, safe and discreet no matter where you live: Ontario, Quebec, Alberta, Nova Scotia, New Brunswick, Manitoba, British Columbia, Prince Edward Island, Saskatchewan, Newfoundland and Labrador. Please, use our United States shop for worldwide delivery. We offer reshipping policy for missing, seized or damaged parcels.

We are working as steroid suppliers since March 2009 and have great experience in catering steroids in Canada with full comfort for customers.

Our support department works 24/7 and always ready to answer any questions and solve any problems if such arise suddenly, all packages have tracking codes. We send notification emails for your order’s status change and you can always check current status via our special online service.

Maxi-Fen-10 is widely known as Nolvadex, Tamoxifen

In Canada there are alternate names for Maxi-Fen-10 (Tamoxifen Citrate): Maxtreme Pharma, Tamoxifen Citrate, Tamoxifen Citrate, Nolvadex 10mg 50 pills, Maxi-Fen-10 10mg 50 pills.

All these are different names of the same substance – Tamoxifen Citrate

Maxi-Fen-10 – Nolvadex, Tamoxifen 10mg Tablet

Tamoxifen citrate is a nonsteroidal agent that has demonstrated potent antiestrogenic properties in animal test systems. The antiestrogenic effects may be related to its ability to compete with estrogen for binding sites in target tissues such as breast. Tamoxifen inhibits the induction of rat mammary carcinoma induced by dimethylbenzanthracene (DMBA) and causes the regression of already established DMBA-induced tumors. In this rat model, tamoxifen appears to exert its antitumor effects by binding the estrogen receptors.

In cytosols derived from human breast adenocarcinomas, tamoxifen competes with estradiol for estrogen receptor protein.

INDICATION

Metastatic Breast Cancer: Tamoxifen citrate tablets are effective in the treatment of metastatic breast cancer in women and men. In premenopausal women with metastatic breast cancer, tamoxifen is an alternative to oophorectomy or ovarian irradiation. Available evidence indicates that patients whose tumors are estrogen receptor positive are more likely to benefit from tamoxifen therapy.

Adjuvant Treatment of Breast Cancer: Tamoxifen citrate tablets are indicated for the treatment of node-positive breast cancer in postmenopausal women following total mastectomy or segmental mastectomy, axillary dissection, and breast irradiation. In some tamoxifen adjuvant studies, most of the benefit to date has been in the subgroup with 4 or more positive axillary nodes.

Tamoxifen is indicated for the treatment of axillary node-negative breast cancer in women following total mastectomy or segmental mastectomy, axillary dissection, and breast irradiation.

The estrogen and progesterone receptor values may help to predict whether adjuvant tamoxifen therapy is likely to be beneficial.

Tamoxifen reduces occurrence of contralateral breast cancer in patients receiving adjuvant tamoxifen therapy for breast cancer.

Ductal Carcinoma in Situ (DCIS): In women with DCIS, following breast surgery and radiation, tamoxifen citrate tablets are indicated to reduce the risk of invasive breast cancer . The decision regarding therapy with tamoxifen for the reduction in breast cancer incidence should be based upon an individual assessment of the benefits and risks of tamoxifen therapy.

Current data from clinical trials support five years of adjuvant tamoxifen therapy for patients with breast cancer